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Objective: The objective of this study was to evaluate the effect of nutritional 
support on proteolysis and plasma amino acid profile in infants early after 
cardiac operations for congenital heart defects. Methods: Thirty-seven 
patients, 2 to 12 months old, were randomized on postoperative day 1 for 
24-hour is0caloric metabolic study. Group STANDARD (18 patients) 
received glucose as the maintenance fluid, and group PN (19 patients) 
received glucose and crystalloid amino acid solution at a dosage of 0.8 + 0.1 
gm/kg per day. The nonprotein caloric intake in the two groups was 25 - 15 
and 33 - 9 kcal/kg, respectively (p = not significant). Results: The nitrogen 
balance was markedly less negative in group PN than in group STANDARD 
(-114 -+ 81 vs -244 __ 86 mg/kg, respectively, p = 0.001). There was a highly 
significant inverse correlation between the nitrogen balance and urinary 
3-methylhistidine xcretion in both groups, but the muscle prote01ysis was 
blunted more effectively in patients receiving amino acids. Concentrations 
of the plasmatic branched-chain amino acids, alanine, glycine, and proline, 
decreased significantly in group STANDARD but not in group PN on 
postoperative day 2. Glutamine and threonine levels declined significantly 
on postoperative day 2 in both groups. Low levels of arginine were observed 
in our patients before operation and in the early postoperative period. The 
amino acid concentrations normalized on postoperative day 7 in all 
patients. Conclusion: Significant proteolysis and hypoaminoacidemia were 
observed in infants early after cardiac operations. This hypercatabolic 
response was blunted by parenteral nutritional support. (J Thorac Cardio- 
vasc Surg 1997;114:1053-60) 
R ecent medical progress allows us to successfully repair almost all congenital heart defects in the 
first months of life, but despite this spectacular 
progress in pediatric ardiac surgery, the postoper- 
ative morbidity in young infants is still higher than 
that in older childrenJ The postoperative morbidity 
is affected by the combined effects of the generalized 
inflammatory reaction triggered by the contact be- 
From Kardiocentrum a and the Department of Clinical Biochem- 
istry, bUniversity Hospital Motol, Prague, Czech Republie. 
Supported by the Grant Agency of the Czech Ministry of Health, 
grant No. 2043=3. 
Received for publicatiori Jt ly 31, 1996; revisions requested Sept. 
16, 1996; revisions reeeived June 10, 1997; accepted for 
publication June 12s 1997. 
Address for reprints: Vficlav Chaloupecl@, MD, Kardiocentrum, 
University Hospital Motol, Vfivalu 84, 150 06 Prague 5, Czech 
Republic. 
Copyright © 1997 by Mosby-Yefir Book, Inc. 
0022-5223/97 $5.00 + 0 12/i/83907 
tween blood and the foreign surfaces of the cardio- 
pulmonary bypass unit TM and the hypercatabolic 
response to stress and trauma in the perioperative 
period. 5 An increased microvascular permeability 
and hypoproteinemia c used by extensive proteoly- 
sis and decreased hepatic albumin synthesis contrib- 
ute to edema formation and secondary organ dys- 
function even in children after complete repair and 
in the presence of good hemodynamic performance. 
Protein metabolism in infants after cardiac oper- 
ations has not been studied extensively even though 
severe undernutrition was observed in one study in 
more than half the children with congenital heart 
defects. 6 This is of clinical importance because 
failure to thrive was a major factor associated with 
increased postoperative morbidity, increased hospi- 
tal costs, and a prolonged hospital stay in patients 
after operations for congenital heart disease] 
We have undertaken a prospective study to deter- 
mine the extent of proteolysis and plasma amino 
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Table I. Diagnosis and surgical repairs 
Diagnosis Procedure Patients 
Ventricular septal defect Patch repair 14 
Transposition of the great Senning 9 
arteries procedure 
Atrioventricular septal defect Double patch 5 
repair 
Double-outlet right ventricle Correction 2 
Anomalous origin of the left Takeushi 1 
coronary artery from the procedure 
pulmonary artery 
Truncus atteriosus Homograft 1 
Atrial septal defect Patch repair 1 
Cor triatriatum Correction 1 
Hemitruncus Correction 1 
Tetralogy of Fallot Correction 1 
Total anomalous pulmonary Correction 1 
venous connection 
Total 37 
acid profi le abnormal i t ies in infants after operat ions 
for congenital  heart  defects. A randomized trial was 
done to evaluate the effect of nutr it ional support  on 
the hypercatabol ic react ion in the early postopera-  
tive period. 
Patients and methods 
The protocol of the study was approved by the Ethical 
Committee of the University HospitM Motok Thirty-seven 
infants, 2 to 1_2 months old (mean 6.7 ~ 3.4 months), 
operated on to correct congenital heart defects with the 
use of cardiopulmonary bypass were entered into the 
prospective metabolic balance study. The body weight of 
the infants ranged from 3.0 to 9.8 kg (mean 5,9 -+ 1.9 kg) 
and the corrected body weight (Z value) from -4.0 to -0.5 
(mean -2.4 2 1.0) of the standard deviation for age- 
matched, normal, healthy Czech children. The diagnoses 
and surgical repairs undertaken are listed in Table I. 
The operations were done with extracorporeal circula- 
tion and deep hypothermia with low flow or circulatory 
arrest. The extracorporeal circuit consisted of a St6ckert 
roller pump and a hollow-fiber oxygenator (Capiox 308, 
Terumo, or Masterflo D 701, Dideco) or a bubble oxygen- 
ator (Bentley Bio 2, Baxter) with a total priming volume of 
approximately 500 ml. The pump circuit was filled with a 
Ringer's olution with heparin, mannitol, and flesh blood 
to achieve a perfusate hematocrit value of about 0.25. The 
total bypass time ranged from 28 to 220 minutes (mean 
88 2 37 minutes) and the duration of ischemia (achieved 
with cold crystalloid cardioplegic solution) was from 9 to 
97 minutes (mea n 48 2 20 minutes). 
Postoperative care. The following parameters were 
monitored continuously (Sirecust 1260, Siemens): sys- 
temic arterial pressure, central venous pressure, left atrial 
pressure, electrocardiogram, and rectal and peripheral 
temperatures. All patients received mechanical ventila- 
tion (BP 2001 Bear or Servoventilator 900C, Siemens) and 
sedation with morphine. 
Table I I .  Composition of the crystalloid amino acid 
solution Nutramin P 8% 
Amino ac id  Abbreviations gm/L 
L-Valine val 6.80 
L-Leucine leu 9.54 
L-Isoleucine ile 6.20 
L-Phenylalanine phe 3.48 
L-Methionine met 2.20 
5-Lysine lys 6.10 
L-Threonine thr 4.10 
L-Tryptophan trp 1.20 
L-Arginine arg 8.30 
L-Histidine his 2.00 
L-Alanine ala 4.10 
L-Glutamic acid glu 8.10 
L-Aspartic acid asp 2.50 
L-Proline pro 6.80 
L-Serine ser 3.30 
Glycine gly 1.50 
L-Cysteine cys 0.37 
N-Acetyl-L-tyrosine tyr 3.54 
Total fluid intake including all maintenance fluids, 
drugs, and flushing volumes for arterial and venous cath- 
eters was restricted on the day of the operation (day 0) to 
50 ml/kg per day and on the first postoperative day (day 1) 
to 75 ml/kg per day. Ten percent glucose was used as the 
basic solution for dilution of catecholamines and KC1 
supplements. The arterial catheter was flushed (Deltran 
II, 3 ml/hr) with normal saline solution and heparin. A 
Foley catheter was used to allow hourly measurements of 
urine output. Urine was collected for 24 hours for the 
determination of levels of electrolytes and urea and of 
3-methylhistidine losses. 
Protocol of the study. The 24-hour metabolic balance 
study started at 6 am on the first postoperative day (day 1) 
and ended at 6 am on the second postoperative day (day 
2). The patients were randomized either to group STAN- 
DARD with a normal fluid regimen or to group PN with 
an early parenteral nutritional support regimen that used 
a pediatric amino acid solution. The planned total fluid 
intake was restricted to 75 ml/kg per day and glucose 
intake was adjusted to approximately 5.0 mg/kg per 
minute in both groups. Patients in group STANDARD 
received as the maintenance fluid 10% glucose, whereas 
patients in group PN received 10% to 20% glucose and a 
commercially available pediatric amino acid solution (Nu- 
tramin P 8%, Spofa) at a planned osage of 1.0 gm/kg per 
day of amino acids. The amino acid composition of 
Nutramin P amino acid solution is shown in Table II. The 
parenteral nutritional support was withdrawn in group PN 
and enteral feeding was gradually reintroduced on post- 
operative day 2 in both groups. All patients received a 
full-strength infant formula by postoperative day 7. 
Blood sampling. Blood samples for determining the 
Concentrations of amino acids and for standard biochem- 
ical and hematologic testing were taken after the induc- 
tion of anesthesia nd each morning on postoperative 
days 1, 2, and 7. 
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Table Ill. Clinical data 
Group 
Group PN STANDARD 
(N = 19) (N = 18) p Value 
Age (too) 6.0 ± 3.2 8.1 _+ 3.4 NS 
Body weight (kg) 5.5 ± 2.0 6.3 _+ 1.7 NS 
Corrected body weight 2.5 _+ 1.1 -2 .2  _+ 0.9 NS 
(Z value) 
Bypass time (min) 88 _+ 27 90 _+ 46 NS 
Aortic crossclamping 5i _+ 18 46 _+ 21 NS 
time (rain) 
Intubation (days) 2.7 _+ 2.3 2.6 _+ 1.7 NS 
Inotropic support 2.1 ± 0.2 2.3 _+ 0.9 NS 
(days) 
Values are given as mean plus or minus the standard eviation. NS, Not 
significant. 
Biochemical analysis. The levels of plasma mino acids 
and 3-methylhistidine i  the urine were measured by the 
chromatographic method on an automatic amino acid 
analyzer (AAA 339 M, Mikrotechna Praha) after depro- 
teinization with sulfosa!icylic acid. The standard biochem- 
ical tests were done on an automatic analyzer (Monarch 
2000, Instrumentation Laboratories, Inc., Watertown, 
Mass.). The total urinary nitrogen level was estimated by 
multiplying the urinary urea content by a factor of 1.2. 
Calculations and statistics. The body weight of the 
patients in the study and individual plasma amino acid 
concentrations were compared with those of normal age- 
matched infants by the Z-value method according to the 
equation Z --- (v -v,J/SD~ where v is the observed value 
and vn and SDn are the average and standard eviation of 
the normal population. Sigma Stat (Jandel Corporation) 
statistical software was used. The time course compari- 
sons within groups were done with one-way repeated- 
measure analysis of variance. When overall significance 
was found a t test for paired samples was used. The 
differences between the two groups were compared by 
unpaired t test. All samples were tested for normality and 
parametric or nonparametric tests were used where ap. 
propriate. Results are expressed as mean and standard 
deviation. Significance was accepted at p < 0.05. 
Results 
Clinical data. All patients survived and were 
discharged from the hospital. Twenty-eight (76%) 
patients were extubated within 72 hours after the 
operation and the remaining nine patients were 
extubated between postoperative days 4 and 9. The 
continuous infusion of catecholamines was discon- 
tinued in all patients within 4 days (median 2 days) 
after the operation. 
Nineteen infants were allocated to group PN and 
18 infants to group STANDARD. The relevant 
clinical data are summarized in Table III. There was 
no difference between the groups regarding age, 
Table IV. Total fluids, glucose, nonprotein calories, 
and amino acid intake on postoperative day 1 
Group 
Group PN STANDARD p Value 
Fluids (ml/kg) 83 -+ 14 73 -+ 18 NS 
Glucose (mg/kg/min) 5.6 _+ 1.5 4.2 _+ 2.6 NS 
Nonprotein calories 33 _+ 9 25 _+ 15 NS 
(kcal/kg) 
Amino acids (gm/kg) 0.8 ± 0.1 
Values are given as mean plus or minus the standard eviation. NS, Not 
significant. 
body weight, bypass time, or aortic crossclamping 
time. The corrected body weight (Z value) was 
lower than -2.0 standard deviations of the body 
weight of the normal population in both groups. The 
postoperative morbidity evaluated as the total intu- 
bation time and inotropic support requirement was 
similar in both groups (Table III). There were no 
severe complications uch as low cardiac output 
syndrome, renal failure, or sepsis in our patients. 
Nine patients required prolonged artificial ventila- 
tion because of fluid retention and increased tra- 
cheobronchial secretions irrespective of the mode of 
nutritional support. 
The total fluids, glucose, and nonprotein caloric 
intake received on the first postoperative day (day 1) 
was similar in both groups (Table IV). The patients 
in group PN received 0.8 _+ 0.1 gm/kg per day of 
amino acids, that is, 112 _+ 20 mg/kg per day of 
nitrogen. There was no difference between the 
groups regarding serum urea or blood glucose con- 
centration. 
Nitrogen balance and 3-methylhistidine excre- 
tion. The nitrogen losses, 3-methylhistidine excre- 
tion, and 3-methylhistidine/creatinine ratio in urine 
were higher on postoperative day 1 in group STAN- 
DARD than in group PN infants, but the difference 
was not significant (Table V). 
The nitrogen balance was markedly less negative 
in patients in group PN at -114 ~ 81 mg/kg than in 
group STANDARD at -244 _+ 86 mg/kg (p = 0.001) 
during the measurement period on postoperative 
day 1. There was a highly significant inverse corre- 
lation between the nitrogen balance and urinary 
3-methylhistidine excretion in both groups (Fig. 1). 
Plasma amino acids. The changes in plasma 
amino acid concentrations are shown in Table VI. 
Compared with preoperative values the branched- 
chain amino acids (BCAA: va!ine, leucine, isoleu- 
cine), alanine, glycine, and proline values decreased 
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Fig. 1. Regression between itrogen balance and 3-meth- 
ylhistidine xcretion during the first postoperative day. 
For group PN, patients receiving early nutritional support 
(open circles, dashed line), the graph shows 3-methylhisti- 
dine = 0.864 -0.0158 × nitrogen balance (p = 0.002); for 
group STANDARD, patients receiving standard fluid 
protocol (closed circles, solid line), the graph shows 3- 
methylhistidine = -2.92 -0.0265 × nitrogen balance (p = 
0.001). 
significantly in group STANDARD but not in group 
PN at the end of the study on postoperative day 2, 
whereas values of glutamine and threonine declined 
significantly in both groups. The plasma amino acid 
concentrations ormalized by postoperative day 7 in 
all patients. 
The BCAA to aromatic amino acid (AAA: phe- 
nylalanine plus tyrosine) ratio (Fig. 2) was reduced 
in the early postoperative period in both groups. 
However, the BCAA/AAA ratio was significantly 
lower in group STANDARD than in group PN at 
the end of the study on postoperative day 2. 
Fig. 3 demonstrates the relative changes (Z value) 
in plasma amino acid concentrations compared with 
reported normal values. 8 The preoperative amino 
acid profile in infants with congenital heart defects 
was in general similar to that of healthy children. 
The early postoperative period (day 1 and day 2) 
was characterized by decreased BCAA and glu- 
tamine levels and increased phenylalanine plasma 
levels. Plasma arginine concentrations were low in 
our patients before operation and during the first 2 
days after the operation. 
Table V. Diuresis and 3-methylhistidine and urinary 
nitrogen excretion on postoperative day 1 
Group 
Group PN STANDARD p Value 
Diuresis (ml/kg) 56 + 25 59 +_ 25 NS 
Nitrogen (mg/kg) 225 _+ 80 244 + 86 NS 
3mHIS (t~mol/kg) 2.6 _+ 1.8 3.5 +_ 2.8 NS 
3mHIS/Cr (txmol/gm) 259 _+ 166 289 _+ 167 NS 
Values given as mean plus or minus the standard eviation. 3mHIS, 
3-Methylhistidine; NS, not significant; 3mHIS/Cr, 3-methylhistidine/creat- 
inine ratio. 
Discussion 
Nitrogen balance and 3-methylhistidine excre- 
tion. We have studied the effects of early paren- 
teral administration of a balanced pediatric amino 
acid solution on overall proteolysis and muscle 
protein breakdown by measuring urinary nitrogen 
losses and 3-methylhistidine excretion. The meta- 
bolic response to stress and trauma in infants 
early after cardiac operations was significant. The 
urinary nitrogen losses observed in our study during 
the first postoperative day were increased to levels 
observed in patients after severe injury or sepsis. 9
3-Methylhistidine xcretion, a unique marker of mus- 
cle proteolysis, was in our patients, corrected per body 
muscle mass (urinary 3-methylhistidine/creatinine ra- 
tio), about hree times higher than values reported for 
healthy subjects 10,11 
The nitrogen balance on postoperative day 1 was 
markedly less negative in infants with amino acid 
supplementation than in infants receiving the usual 
fluid regimen. We also documented a highly signif- 
icant inverse correlation between the 3-methylhisti- 
dine excretion and the daily nitrogen balance indi- 
cating an association between nitrogen retention 
and reduction in muscle proteolysis as observed in 
other patients with hypercatabolism. 11-13 The con- 
siderable variation in 3-methylhistidine excretion in 
our patients corresponded to the individual re- 
sponse to trauma and stress in the postoperative 
period. However. the less steep slope of the linear 
correlation curve in infants in group PN suggested 
that nutritional support with use of the amino acid 
solution blunted the muscle proteolysis more effec- 
tively than glucose alone. 
Plasma amino acids. The changes in amino acid 
metabolism after cardiac operations have been. to 
our knowledge, studied only in adults. 14-~7 We have 
observed in infants transiently but significantly de- 
creased plasmatic BCAA, glutamine, alanine, gly- 
cine, threonine, proline, and arginine levels and 
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Table V1. Plasma amino acid concentrations 
Preop. Day 1 Day 2 Day 7 F value p Value 
L-Aspartic acid 11.9 ± 6.5* 23.6 ± 17.5? 17.7 _+ 11.2t 13.8 ± 8.5 5.23 0.004 
18.6 ± 13.0 13.5 ± 12.2 12.8 _+ 7.6 20.6 ± 16.8 2.41 NS 
L-Glutamic acid 72.4 + 30.7 73.7 ± 41.4 60.2 ± 23.9 65.5 _+ 22.1 1.13 NS 
68.8 _+ 41.5 61.4 + 33.7 44.6 ± 22.4 65.9 _+ 25.2 1.68 NS 
c-Arginine 33.9 _+ 13.0 19.2 ± 10.9t 30.8 ± 15.8 46.6 _+ 28.2 7.66 0.001 
33.5 _+ 13.4 24.4 2 11.9 24.5 ± 9.9 42.2 _+ 19.2 4.65 0.008 
L-Lysine 89.6 _+ 31.8 67.3 + 27.1]" 79.7 ± 30.4 135.5 _+ 84.3 8.21 0.001 
90.6 _+ 32.9 73.5 ± 31.1t 73.5 ± 30.5 138.5 ± 78.3 9.24 0.001 
L-Histidine 59.9 ± 18.2 59.0 ± 24.6 65.1 +_ 30.5 77.9 ± 47.8 1.18 NS 
63.2 _+ 23.6 63.3 ± 22.0 54.5 ± 24.1 73.4 _+ 33.1 0.82 NS 
L-Glutamine 409.2 _+ 105.6 324.2 + 113.4t 278.3 + 95.5t 397.4 _+ 204.5 3.63 0.020 
401.8 _+ 134.4 384.8 + 148.6 287.6 ± 86.4t 479.0 _+ 175.9 8.67 0.001 
L-Alanine 199.5 _+ 52.3 175.4 + 96.5 188.6 _+ 101.4 195.8 ± 88.0 0.66 NS 
176.3 ± 61.8 193.1 + 96.9 128.9 _+ 55.2? 207.4 ± 59.5 5.06 0.005 
L-Isoleucine 39.3 ± 11.3 31.0 ± 21.0 35.1 _+ 11.7 40.0 ± 16.1 1.76 NS 
38.1 _+ 13.1 34.2 + 21.8 23.7 + 23.7t~ 54.9 ± 29.4 6.91 0.001 
L-Val ine 137.8 _+ 43.1 123.8 ± 60.7 130.1 ± 38.1 144.5 _+ 66.0 0.51 NS 
136.2 _+ 41.1 127.7 ± 55.2 90.6 ± 35.0t-~ 169.1 _+ 56.4 7.60 0.001 
L-Leucine 73.9 ± 18.2 63.9 ± 18.0 68.4 ± 20.2 88.3 _+ 33.3 3.44 0.024 
73.1 ± 22.5 77.3 ± 38.4 47.6 ± 17.7t:~ 108.8 _+ 56.0 6.77 0.001 
L-Glycine 146.2 _+ 43.4 157.1 ± 77.2 127.1 + 44.6 133.3 ± 46.7 1.57 NS 
147.4 _+ 53.1 141.2 _+ 50.1 119.1 ± 34.1~ 175.6 ± 55.8 3.98 0.014 
L-Proline 132.2 _+ 42.4 86.9 --+ 34.2~ 100.1 + 32.1 206.4 ± 82.2 18.8 0.001 
110.4 _+ 42.2 90.4 --+ 37.9 67.7 +_ 27.6t$ 127.2 + 30.5 14.8 0.001 
L-Phenylalanine 50.0 _+ 19.3 63.7 ± 24.0t 73.3 _+ 26.0~ 52.5 ± 23.2 6.67 0.001 
49.0 _+ 17.6 67.2 _+ 24.5t 63.4 _+ 23.2 61.7 _+ 25.4 3.49 0.024 
N-Acetyl-Iztyrosine 57.4 ± 20.1 54.7 ± 21.9 50.4 ± 17.0 71.1 _+ 32.2 5.17 0.004 
53.4 ± 16.1 57.9 + 23.9 42.7 ± 13.9 79.9 _+ 39.4 7.35 0.001 
L-Tryptophan 20.7 + 10.0 24.1 -- 9.6 26.1 ± 15.5 16.1 _+ 12.0 1.57 NS 
23.3 ± 10.6 28.4 + 13.3 19.9 ± 17.4 35.1 ± 20.2 1.71 NS 
L-Serine 93.3 ± 29.8 75.1 ± 47.2 73.8 ± 31.1t 90.1 ± 21.7 2.44 NS 
87.8 ± 38.6 71.0 ± 26.0 67.7 ± 20.9 108.8 ± 47.7 7.91 0,005 
L-Threonine 76.6 _+ 31.7 55,3 _+ 28.6 55.4 ± 20.3? 102.3 + 60.3 6.30 0.001 
64.1 ± 37.9 53.6 ± 24.8? 43.6 _+ 15.5t:~ 122.1 ± 67.1 t2.8 0.001 
L-Cysteine 55.4 ± 13.8 31.4 _+ 16.9? 41.1 _+ 17.57 62.8 ± 27.4 7.01 0.001 
46.4 ± 15.9 39.0 ± 14.57 37.2 ± 13.6 58.0 _+ 17.5 6.57 0.001 
L-Methionine 18.0 ± 6.3 14.4 ± 6.0 17.2 ± 6.1 20.9 _+ 11.3 1.71 NS 
15.2 _+ 6,6 15.7 _+ 7.4 11.7 ± 5.9 23.5 _+ 13.3 3.97 0.014 
L-Taurine 49.4 ± 35.2 44.6 ± 35.4 51.9 -+ 39.5 59.5 + 40.0 1.27 NS 
54.2 ± 42.3 49.6 ± 28.5 59.6 ± 30.1 60.1 ± 47.9 0.39 NS 
Values are given as mean plus or minus the standard deviation. NS, Not significant. 
*Top numbers are for group PN; bottom numbers are for group STANDARD. 
?p < 0.05 versus preoperative values. 
Sp < 0.05 between group PN and group STANDARD. 
elevated phenylalanine levels in the early postoper- 
ative period. Stress and trauma cause an extensive 
muscle proteolysis with a resultant release of amino 
acids into the plasma for oxidative metabolism 
and for the protein synthesis involved in the 
immune reactions, healing, and vital organs func- 
tion. 5 Both main factors responsible for muscle 
proteolysis, increased levels of the major stress 
hormones (epinephrine, cortisol, and gluca- 
gon)2, 18, 19 and activated cytokine mediators, 3'4 
have been documented in patients after cardiac 
operations. 
The decrease of some plasma amino acids in our 
study indicated a mismatch between their endogenic 
supply and increased demands in infants early after 
cardiac operations. Because the skeletal muscle has 
been recognized as the principal source of BCAAs, 
glutamine, and alanine in adults after cardiac oper- 
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Fig. 2. The BCAA/AAA (phenylalanine plus tyrosine 
[phe + tyr]) ratio. *p < 0.05 versus preoperative values; 
#p < 0.05 between patients receiving the standard fluid 
protocol (group STANDARD) and patients receiving 
early nutritional support (group PN). 
ations, 15 it is probable that infants with congenital 
heart defects and dystrophy have a limited endoge- 
nous pool of amino acids. Reduced BCAA/AAA 
ratios observed in our patients also suggest an 
increased clearance of BCAA and impaired hepatic 
uptake of AAAs as in other critically ill patients. 5 
The clinical consequence of hypoaminoacidemia 
in infants early after cardiac operations remains to 
be established, but we have demonstrated that ex- 
cept for the level of glutamine this can be blunted by 
amino acid supplementation. The Nutramin P 8%, 
Spofa, used in our study is a commercially available 
glutamine-free p diatric amino acid solution with an 
increased concentration of BCAAs (28.2%), gluta- 
mate (10%), and proline (8.5%). The decline in 
plasma glutamine levels in infants early after the 
cardiac operation was alarming. Glutamine is the 
key amino acid for the metabolism of intestinal 
tract, renal tubular cells, endothelial cells, and the 
immune system. 2° Although glutamine is the most 
abundant amino acid in the human body it becomes 
an indispensable nutritional component in the crit- 
ically ill patient. 2° Unfortunately, because of its 
rapid disintegration i water glutamine is not avail- 
able in commercial amino acid solutions for paren- 
teral administration. 
The BCAAs are a crucial metabolic substrate for 
patients with hypercatabolism, particularly in sepsis 
and hepatic failure, s Although the normal heart 
extracts only a small amount of amino acids, during 
ischemia nd reperfusion the BCAAs and glutamate 
are important substrates for myocardial energy me- 
tabolism and protein synthesis, 15-17 particularly in 
the immature heart. 21 
Low plasma arginine levels were observed in our 
patients preoperatively and early after operation. 
Because nitric oxide is synthesized from L-arginine, 
the low arginine levels may be important for infants 
with an increased pulmonary vascular eactivity in 
the early postoperative period, but the clinical sig- 
nificance of this interesting observation is not 
known. It was demonstrated that both systemic and 
pulmonary vascular esistance decreased in critically 
ill patients after intravenous L-arginine administra- 
tion. 22 Moreover, the beneficial effects of L-arginine 
after hypothermic schemia nd reperfusion in neo- 
natal hearts were confirmed. 23 
Clinical outcome. We have confirmed in our 
study the presence of an extensive proteolysis and 
significant hypoaminoacidemia e rly after cardiac 
operations in infants with limited metabolic re- 
serves. Parenteral amino acid administration on the 
first postoperative day blunted the proteolysis more 
effectively than glucose alone, but the higher caloric 
intake in group PN, although it was not signifi- 
cant, could have been also influential. The plasma 
amino acid profile normalized within 1 week af- 
ter the operation in our selected group of patients 
with uncomplicated recovery. Therefore parenteral 
amino acid supplementation is not necessary in 
infants with normal postoperative convalescence in 
whom early enteral nutrition is emphasized. 
On the other hand, we would strongly recom- 
mend parenteral nutritional support in stressed 
infants with severe circulatory failure and other 
complications such as capillary leak, renal failure, 
and sepsis that are usually followed by gastroin- 
testinal subsystem dysfunction. However, paren- 
teral nutrition in infants early after cardiac oper- 
ations presents ome specific problems. The usual 
fluid protocol used in infants, 24 because of neces- 
sary volume restriction, covers only about 50% of 
the measured energy expenditure, according to 
data published by Gebara, Gelmini, and Sarnaik 25 
in children early after operation for congenital 
heart defects. The substrate utilization in the 
same study also showed a shift toward fat oxida- 
tion and either gluconeogenesis or impaired 
carbohydrate utilization. The role of intravenous 
lipid emulsions in children early after cardiac 
operations remains to be clarified because of their 
rather unpredictable pharmacologic effects on the 
pulmonary vascular eactivity, lung function, and 
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Fig. 3. The relative mean plasma amino acid concentrations (Z values) with regard to reported normal 
values. The solid circle equals zero standard eviation from the control group. Each dotted circle represents 
the difference of one standard eviation from the mean of the normal values. Group PN, patients receiving 
early nutritional support, is indicated by the dashed line; group STANDARD, patients receiving standard 
fluid protocol, is indicated by the solid line. Gln, Glutamine; tau, L-taurine; orn, L-ornithine. Other 
abbreviations a in Table II. 
immune response in critically ill patients. 26 There- 
fore amino acids are an essential metabolic fuel in 
children with hypercatabolism early after cardiac 
operations and, even more notably, they may have 
important but yet not fully understood pharmaco- 
logic effects in patients with unstable circulation. 
Conclusion. Extensive muscle proteolysis and hy- 
poaminoacidemia were confirmed in infants early 
after cardiac operations for congenital heart defects. 
This hypercatabolic response was blunted by paren- 
teral nutritional support. Intravenous amino acid 
administration should be considered in the complex 
1 0 6 0 Chaloupecl~ et al. 
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treatment of children stressed by a complicated 
postoperative course and gastrointestinal system 
dysfunction. 
REFERENCES 
1. Kirklin JK. Prospects for understanding and eliminating the 
deleterious effects of cardiopulmonary b pass. Ann Thorac 
Surg 1991;51:529-31. 
2. Downing SW, Edmunds LH Jr. Release of vasoactive sub- 
stances during cardiopulmonary b pass. Ann Thorac Surg 
1992;54:1236-43. 
3. Butler J, Rocker GM, Westaby S. Inflammatory response to 
cardiopulmonary b pass. Ann Thorac Surg 1993;55:552-9. 
4. Butler J, Pathi VL, Paton RD, et al. Acute-phase responses 
to cardiopulmonary b pass in children weighing less than 10 
kilograms. Ann Thorac Surg 1996;62:538-42. 
5. Siegel JH, Goodzari S, Gaudelupi P, et al. The host defense 
to trauma and sepsis: multiple organ failure as a manifesta- 
tion of host defense failure disease. In: Schlag G, Redl H, 
editors. Pathophysiology of shock, sepsis, and organ failure. 
Berlin, Heidelberg, New York: Springer-Verlag; 1993. p. 
627-64. 
6. Mitchell IM, Logan RW, Pollock JCS, Jamieson MPG. 
Nutritional status of children with congenital heart disease. 
Br Heart J 1995;73:277-83. 
7. Silberbach M, Shumaker D, Menashe V, Cobanoglu A, Morris 
C. Predicting hospital charge and length of stay for congenital 
heart disease surgery. Am J Cardiol 1993;72:958-63. 
8. Liappis N, Gobien N, Schlebusch H. Referenzwerte fur die 
Konzentration der freien Aminosauren im Nuchternserum 
yon Kindern. Klin Padiatr 1990;202:161-7. 
9. Iapichino G, Radrizzani D. Anabolic drive in critically ill 
patients: pros and cons of a prevailing lucose system. In: 
Wilmore DW, Carpentier YA, editors. Metabolic support of 
the critically ill patient. 1st ed. Berlin, Heidelberg: Springer- 
Verlag; 1993. p. 137-56. 
10. Lukaski HC, Mendez J, Bushkirk ER, Cohn SH. Relation- 
ship between endogenous 3-methylhistidine excretion and 
body composition. Am J Physiol 1981;240:E302-7. 
11. Seashore JH, Huszar GB, Davis EM. Urinary 3-methylhisti- 
dine excretion and nitrogen balance in healthy and stressed 
premature infants. J Pediatr Surg 1980;15:400-4. 
12. Radrizzani D, Iaipichino G, Cambisano M, Bonetti G, Ron- 
zoni G, Colombo A. Peripheral, visceral and body nitrogen 
balance of catabolic patients, without and with parenteral 
nutrition. Intensive Care Med 1988;14:212-6. 
13. Aguilaniu B, Goldstein-Shapes S, Pajon A, et al. Muscle 
protein degradation i  severely malnourished patients with 
chronic obstructive pulmonary disease subject o short-term 
total parenteral nutrition. JPEN J Parenter Enteral Nutr 
1992;16:248-54. 
14. Herskowitz K, Plumley DA, Martin TD, Hautamaki RD, 
Copeland EM, Souba WW. Lung glutamine ftmx following 
open heart surgery. J Surg Res 1991;51:82-6. 
15. Svedjeholm R, Svensson S, Ekroth R, et al. Trauma metab- 
olism and the heart: studies of heart and leg amino acid flux 
after cardiac surgery. Thorac Cardiovasc Surg 1990;38:1-5. 
16. Svedjeholm R, Ekroth R, Joachimsson PO, Ronquist G, 
Svensson S, Tyden H. Myocardial uptake of amino acids and 
other substrates in relation to myocardial oxygen consump- 
tion four hours after cardiac operations. J Thorac Cardiovasc 
Surg 1991;101:688-94. 
17. Svedjeholm R, Hakanson E, Vanhanen I. Rationale for 
metabolic support with amino acids and glucose-insulin- 
potassium (GIK) in cardiac surgery. Ann Thorac Surg 1995; 
59:$15-22. 
18. Ratcliffe JM, Wyse RKH, Hunter S, Alberti KGMM, Elliott 
MJ. The role of the priming fluid in the metabolic response 
to cardiopulmonary b pass in children of less than 15 kg body 
weight undergoing open-heart surgery. Thorac Cardiovasc 
Surg 1988;36:65-74. 
19. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic 
stress responses in neonates undergoing cardiac surgery. 
Anesthesiology 1990;73:661-70. 
20. Souba WW, Klimberg VS, Plumley DA, et al. The role of 
glutamine in maintaining a healthy gut and supporting the 
metabolic response to injury and infection. J Surg Res 
1990;48:383-91. 
21. Julia PL, Young HH, Buckberg GD, Kofsky ER, Bugyi HI. 
Studies of myocardial protection in the immature heart. IV. 
Improved tolerance of immature myocardium to hypoxia and 
ischemia by intravenous metabolic support. J Thorac Cardio- 
vasc Surg 1990;101:23-32. 
22. Lorente JA, Landin L, De Pablo R, Renes E, Liste D. 
1-Arginine pathway in the sepsis syndrome. Crit Care Med 
1993;21:1287-95. 
23. Hiramatsu T, Forbess JM, Miura T, Nomura F, Mayer JE. 
Additive effects of L-arginine infusion and leukocyte deple- 
tion on recovery after hypothermic ischemia in neonatal lamb 
hearts. J Thorac Cardiovasc Surg 1995;110:172-9. 
24. Sumner E, Stark J. Postoperative care. In: Stark J, de Leval 
M, editors. Surgery for congenital heart defects. 2nd ed. 
Philadelphia: WB Saunders; 1994. p. 193-233. 
25. Gebara BM, Gelmini M, Sarnaik A. Oxygen consumption, 
energy expenditure, and substrate utilization after cardiac 
surgery in children. Crit Care Med 1992;20:1550-4. 
26. Skeie B, Askanazi J, Rothkopf MM, Rosenbaum SH, Kvetan 
V, Thomashow B. Intravenous fat emulsions and lung func- 
tion: a review. Crit Care Med 1988;16:183-94. 
